EUVIMEDEUVIMED entdecken
Open Access

Differential expression of a disease-associated MRE11 variant reveals distinct phenotypic outcomes

McKenna B DeFoer, Ahmed M Mostafa, Andrea J Hartlerode, Steven K Orban, Keegan McDonough, Sophie Quirk, Brianna K L Ferguson, David O Ferguson iD, JoAnn M Sekiguchi iD

Human Molecular Genetics · 18.11.2025 · 34 (23) · 1964-1978

DOI: 10.1093/hmg/ddaf154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, online erschienen am 11.10.2025. Verfasst von McKenna B DeFoer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, University of Michigan Medical School, 109 Zina Pitcher Place, Rm 2063, Ann Arbor, MI 48109-2200, United States. Hauptthemen laut MEDLINE: MRE11 Homologue Protein, Ataxia Telangiectasia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHLBI NIH HHS, National Institutes of Health, USA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The MRE11 DNA nuclease plays central roles in the repair of DNA double-strand breaks (DSBs) as a core component of the MRE11-RAD50-NBS1 (MRN) complex. MRN localizes to chromosomal DSBs and recruits and activates the DSB repair protein kinase, ATM, which phosphorylates downstream substrates to elicit cellular DNA damage responses. Pathogenic variants in MRE11 cause the genome instability disorder ataxia-telangiectasia-like disorder (ATLD). The first ATLD patient allele identified, ATLD1, is a nonsense mutation that deletes 76 residues from the MRE11 C-terminus and markedly reduces levels of MRE11-ATLD1 and the entire MRN complex. The MRE11 C-terminus has been demonstrated to function in DNA binding, mediate protein interactions, and undergo post-translational modifications that regulate the MRE11 nuclease. We previously demonstrated that transgenic mice expressing reduced wildtype MRN levels exhibit severe phenotypes, including small body size, anemia, and DNA DSB repair defects. Thus, it is currently unknown whether low MRE11-ATLD1 levels, loss of the C-terminus, or both cause disease-associated phenotypes. In this study, we generated transgenic mouse models that express near endogenous or significantly reduced levels of MRE11-ATLD1 to determine the in vivo importance of the MRE11 C-terminus. We observe that low MRE11-ATLD1 expression leads to anemia, bone marrow failure, extramedullary hematopoiesis, and impaired lymphocyte development, similar to mice expressing low wildtype MRE11. In contrast, higher MRE11-ATLD1 expression results in a subset of moderate phenotypes, indicating that loss of the C-terminus has limited impact on MRN functions in vivo. These findings provide a foundation for predicting the clinical presentation and severity of ATLD patient phenotypes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MRE11 Homologue ProteinAtaxia TelangiectasiaHumansAnimalsMiceDNA Breaks, Double-StrandedDNA RepairPhenotypeMice, TransgenicDNA-Binding ProteinsAtaxia Telangiectasia Mutated ProteinsAcid Anhydride HydrolasesCell Cycle ProteinsDNA Repair Enzymes

Stichwörter der Autor:innen

DNA repairgenome instabilityhematopoiesislymphocyte development

Substanzen

MRE11 Homologue ProteinMRE11 protein, humanDNA-Binding ProteinsAtaxia Telangiectasia Mutated ProteinsAcid Anhydride HydrolasesCell Cycle ProteinsDNA Repair Enzymes

Autor:innen und Institutionen

  • Department of Human Genetics, University of Michigan Medical School, 109 Zina Pitcher Place, Rm 2063, Ann Arbor, MI 48109-2200, United States.
  • Department of Pathology, University of Michigan Medical School, 109 Zina Pitcher Place, Rm 2067, Ann Arbor, MI 48109-2200, United States.
  • Department of Biochemistry, Faculty of Pharmacy, Ain Shams University, African Union Authority St., Abbassia, Cairo 11566, Egypt.

ORCID-Profile: David O Ferguson, JoAnn M Sekiguchi

Förderung

  • NCI NIH HHS
  • NHLBI NIH HHS
  • National Institutes of Health, USA
  • The University of Michigan Cancer Center Support
  • National Institutes of Health
  • The University of Michigan Cancer Center
  • University of Michigan Transgenic Animal Model Core

Zitieren

APA

DeFoer, M. B., Mostafa, A. M., Hartlerode, A. J., Orban, S. K., McDonough, K., Quirk, S., Ferguson, B. K. L., Ferguson, D. O., & Sekiguchi, J. M. (2025). Differential expression of a disease-associated MRE11 variant reveals distinct phenotypic outcomes. Human Molecular Genetics, 34(23), 1964-1978. https://doi.org/10.1093/hmg/ddaf154

Vancouver

DeFoer MB, Mostafa AM, Hartlerode AJ, Orban SK, McDonough K, Quirk S, et al. Differential expression of a disease-associated MRE11 variant reveals distinct phenotypic outcomes. Human Molecular Genetics. 2025;34(23):1964-1978. doi:10.1093/hmg/ddaf154

BibTeX
@article{DeFoer2025,
  author = {DeFoer, McKenna B and Mostafa, Ahmed M and Hartlerode, Andrea J and Orban, Steven K and McDonough, Keegan and Quirk, Sophie and Ferguson, Brianna K L and Ferguson, David O and Sekiguchi, JoAnn M},
  title = {Differential expression of a disease-associated MRE11 variant reveals distinct phenotypic outcomes},
  journal = {Human Molecular Genetics},
  year = {2025},
  volume = {34},
  number = {23},
  pages = {1964--1978},
  doi = {10.1093/hmg/ddaf154}
}
Kostenlos starten →